L-carnitine transport and metabolism: Role in skeletal muscle and beyond
The proposed treatment strategies involve pharmacological and non-pharmacological approaches, including -blockers, ivabradine, pyridostigmine, fludrocortisone, midodrine, increased salt and fluid intake, intravenously administered salt, compression stockings for treatment of POTS, Coenzyme Q 10 , D-ribose for fatigue, anticoagulants and apheresis for abnormal clotting, Sulodexide and Pycnogenol for ED (5, 128)
Reported side effects include mild skin irritation and redness
If weight loss plateaus after optimizing a single GLP-1 therapy, adding a second agent should occur only under close medical supervision with clear biomarker tracking
Search Within Type of Search Limit to a Database Search Databases Manually by Outline Summary: Editor: Anthony J
IGF-1 levels rise by 20 to 40% in most treated patients, providing an objective marker of treatment response that clinicians can track with routine blood work
